|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.590 GBX | +7.24% |
|
-0.22% | +14.75% |
| 15/04 | Windar hails 'strongest ever first quarter' | AN |
| 15/04 | Poolbeg Pharma Secures Topical Trial Authorization for POLB 001 Therapy in UK | MT |
Main competitors
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
 | - | - | -4.32x | 3.57x | - | -4.26x | -3.97x | 4.08Cr | |
| 0.05% | 0.12% | 28.36x | 5.53x | 7.48x | 22.28x | 23.46x | 5.02TCr | |
| 1.75% | 1.86% | 16.9x | 3.12x | 5.07x | 11.51x | 13.36x | 4.36TCr | |
| -.--% | -.--% | -54.72x | 63.28x | 17.39x | -58.82x | -59.75x | 3.04TCr | |
| -.--% | -.--% | -20.9x | 1.26x | 5.55x | -10.88x | -8.44x | 2.82TCr | |
| -.--% | -.--% | -21.2x | 101.19x | 2544.1x | -29.53x | -20.6x | 2.05TCr | |
| -.--% | -.--% | 28.04x | 2.64x | 5.48x | 15.23x | 19x | 1.87TCr | |
| -.--% | -.--% | -444.22x | 14.75x | 34.97x | 4390.34x | -421.28x | 1.73TCr | |
| -.--% | -.--% | 22.63x | 2.45x | 3.91x | 11.97x | 14.47x | 1.67TCr | |
| -.--% | -.--% | -503.17x | 20.63x | 36.35x | -2284.69x | -359.1x | 1.49TCr | |
| -.--% | -.--% | -110.84x | 19.05x | 7.77x | -219.02x | -85.01x | 1.21TCr | |
| -.--% | -.--% | 15.01x | 3.87x | 4.12x | 9.76x | 11.01x | 1.17TCr | |
| -.--% | -.--% | 15.79x | 8.06x | 9.53x | 15.89x | 15.6x | 1.04TCr | |
| -.--% | -.--% | -20.56x | 40.83x | 21.56x | -24.42x | -19.96x | 994.93Cr | |
| -.--% | -.--% | -8.2x | - | - | -7.28x | -7.06x | 871.44Cr | |
| -.--% | -.--% | -18.85x | 8.33x | 547.24x | -16.15x | -16.56x | 842.22Cr | |
| -.--% | -.--% | -10.12x | -17.91x | 85.19x | -10.79x | -10.43x | 810.41Cr | |
| Average | 0.11% | 0.12% | -64.14x | 17.54x | 222.38x | 106.54x | -53.84x | 1.82TCr | |
| Weighted average by Cap. | 0.25% | 0.28% | -52.64x | 19.22x | 200.56x | 123.33x | -45.07x |
- Stock Market
- Equities
- POLB Stock
- Sector Poolbeg Pharma PLC
- Sector dividends
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition